Sun Pharmaceutical Industries Limited — Board Meeting, 31-07-2026: Outcome of Board Meeting
31-07-2026 | 02:30 pm
31-07-2026 | 02:30 pm
Sun Pharma's Board approved Q1 FY27 results. Sales rose 10.1% to ₹15,184 Cr, with net profit ₹2,895 Cr. India sales +16%, and Global Innovative Medicines +12.8%. Organon acquisition is on track for early 2027 close after shareholder nod.
No comments yet. Be the first to comment!
All announcements from Sun Pharmaceutical Industries Limited
